INTRODUCTION
Patients with decompensated cirrhosis have high incidence of sepsis. The prevalence of sepsis is about 30-50% in patients hospitalized for acute hepatic decompensation [1]. Spontaneous bacterial peritonitis and urinary tract infection are the most common infections among patients with cirrhosis, followed by chest infection, cellulitis and spontaneous bacteremia [2] . These different types of infections induce excessive systemic inflammation that may lead to decompensation, organ failure and acute-on-chronic liver failure in patients with cirrhosis [3] .
Diagnosis of sepsis is still challenging in general population. There is no standard diagnostic test that allows easy and accurate diagnosis of sepsis [4] . Systemic inflammatory response syndrome (SIRS) criteria (at least two of the following: body temperature <36°C or >38°C; heart rate >90 bpm, respiratory rate >20/min, white blood cells [WBC] <4.000/μL or >12.000/μL or immature neutrophils >10%) were used for diagnosing sepsis in cirrhosis [5] . However, it may be difficult to prove infection in addition to the previous criteria or the results are delayed. Also, patients with cirrhosis may have leucopenia because of hypersplenism, tachypnea because of hepatic encephalopathy or ascites, and/ or bradycardia because of the use of beta-blockers which make the clinical judge is more difficult [1]. Thus, SIRS criteria are ineffective for diagnosing sepsis in cirrhosis. Recently, organ dysfunction due to sepsis is defined as a change in sequential organ failure assessment (SOFA) score ≥ 2 points or positive quick SOFA (at least two of the following: alteration in mental status, systolic blood pressure ≤100 mm Hg or respiratory rate ≥22/min). Both scores are used recently instead of systemic inflammatory response syndrome (SIRS) criteria [5] . Both Sepsis-3 criteria and qSOFA were shown to be more accurate than SIRS criteria in predicting in-hospital mortality in patients with cirrhosis and bacterial infections [6] . As rapid diagnosis of sepsis in cirrhotic patients is a critical issue, there is a need for diagnostic scoring systems to facilitate early detection of sepsis. So, we aimed in this study to evaluate the existing scoring systems in our patients with liver cirrhosis to identify patients with sepsis in the context of available clinical and laboratory data.
PATIENTS AND METHODS
This prospective study included 288 consecutive patients previously diagnosed to have liver cirrhosis and suspected to have bacterial/fungal infections. They were selected among patients with cirrhosis were admitted to Intensive Care Unit (ICU) of tropical medicine and anaesthia departments, Zagazig University hospitals during the period between January 2018 and May 2018. Variables for sepsis criteria were calculated within 24 h after the admission. Quick Sequential (sepsis-related) organ failure assessment (qSOFA) criteria and sepsis-3 criteria were used to identify patients with organ dysfunction due to sepsis. Baseline SOFA was assessed using preadmission data. Acute changes in SOFA score of 2 points or more represent organ dysfunction. After infection was suspected, patients were meticulously evaluated and promptly treated with empirical broad-spectrum antibiotic combination, depending on the site of infection, known colonization and previous antibiotic treatment. Antifungal therapy was added if fungal infection was suspected or documented. Antimicrobial treatment was narrowed after identification of the responsible pathogen. The patients were followed up until discharge or death. The area under the receiver operating characteristic curve (AUROC) value for a model with qSOFA was AUROC: 0.77 (95%CI, 0.68-0.85) (Fig. 5) and that for sepsis-3 criteria was AUROC: 0.76 (CI; 0.68-0.85) (Fig. 6) , while AUROC value for a model with SIRS criteria was lower AUROC: 0.66 (95%CI, 0.57-0.75) (Fig. 7) . 
Sequential

DISCUSSION
Sepsis is defined as life-threatening organ dysfunction due to a dysregulated host response to infection [4] . There is no gold standard test for diagnosis of sepsis but several clinical and laboratories data are used to identify patients with sepsis. Sepsis-3 criteria and qSOFA are widely used for prediction of sepsis in general population. However, their use in patients with cirrhosis is not yet adequately studied. Piano et al. [6] were the first to study the predictive validity of both sepsis-3 criteria and qSOFA in patients with cirrhosis and bacterial/fungal infections. They reported that both sepsis-3 criteria and qSOFA are superior to SIRS criteria in predicting severity of infection and mortality among patients with cirrhosis. Our study was aimed at evaluation of these criteria in identification of sepsis and to detect the predictive validity inhospital mortality in patients with cirrhosis.
The patients included in this study have decompensated cirrhosis based on clinical, laboratory and radiological data. The underlying cause of cirrhosis in most patients was chronic viral hepatitis (B and C), due to its high prevalence in the Egyptian community. Urinary tract infection and spontaneous bacterial peritonitis were the most common infections. The body fluid cultures were positive in 76% of patients, Sepsis-3 and qSOFA criteria were positive in 33% and 30% of patients respectively. In Piano et al. [7] , the underlying cause of cirrhosis in most patients was alcohol. The cultures were positive in 57% of patients and qSOFA criteria were positive in 23% of patients. This discrimination may be attributed to high incidence of bacterial rather than fungal or viral infections in our cirrhotic patients (alcoholics are more immunecompromised).
Sepsis -3 and qSOFA criteria had significantly greater predictive validity for in-hospital mortality (area under the receiver operating characteristic curve (AUROC) =0.768 and 0.770 respectively) than SIRS (AUROC=663). These results are consistent with that observed by Piano et al. [7] . AUROC for sepsis-3 and qSOFA are 0.784 and 0.732 respectively, while AUROC for sepsis was 0.606. This high discrimination validity of both sepsis-3 and qSOFA criteria allow the use of these criteria as a bed side tool for early detection of cirrhotic patients with poor outcomes and hence apply more intensive management. Although high validity of both scores in detecting high risk patients, the need for objective laboratory markers may confer better detection of sepsis. So, further studies focusing on laboratory markers are needed.
CONCLUSION
Sepsis-3 and qSOFA are more accurate than SIRS criteria in early detection of sepsis among patients with cirrhosis. Patients with positive criteria need intensive management due to high risk of in-hospital mortality.
